MICS + trabeculectomy a good match

Article

Microincision cataract surgery (MICS) combined with trabeculectomy provides a one-year intraocular pressure (IOP) control comparable to that found with trabeculectomy and separate temporal clear corneal phaco, according to the results of a study by Dr Bayer and colleagues from the Ankara School of Medicine, Turkey.

Microincision cataract surgery (MICS) combined with trabeculectomy provides a one-year intraocular pressure (IOP) control comparable to that found with trabeculectomy and separate temporal clear corneal phaco, according to the results of a study by Dr Bayer and colleagues from the Ankara School of Medicine, Turkey.

A total of 63 eyes with co-existing cataract and glaucoma were randomly assigned to receive mitomycin-C (MMC) trabeculectomy in the superior quadrant combined with phaco and foldable intraocular lens (IOL) implantation through a separate, temporal, clear corneal incision (2-site group) or MMC trabeculectomy in a superior quadrant combined with MICS followed by IOL implantation from the trabeculectomy incision.

Mean preoperative IOP was 28.1±7.1 mmHg and 27.7±6.5 mmHg in the 2-site and MICS groups, respectively. At six-months postoperatively, mean IOP was 14.9±4.3 and 14.3±3.8 mmHg, respectively (p=0.7) and at 12 months, 15.6±3.3 and 15.1±3.1 mmHg, respectively (p=0.5). Postoperative astigmatic change and complications were comparable between the groups.

Dr Bayer concluded that MICS with trabeculectomy and trabeculectomy with separate temporal clear corneal phaco provide comparable IOP control at one-year.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
Related Content
© 2025 MJH Life Sciences

All rights reserved.